Open original FDA record ↗Recall record
- FDA identifier
- Z-0128-2011
- Company in FDA record
- Hospira Inc
- FDA classification date
- Oct 22, 2010
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Hospira has identified motor encoder failures in the Symbiq pumping mechanism that causes the infuser to cease operation during infusion therapy, resulting in delay or interruption of infusion therapy.
Source facts
- Action
- Hospira issued a Recall Notification letter dated October 4, 2010, updating the Urgent Device Field Correction letter dated February 22, 2010, ideentifying the affected products, the issue prompting the recall, and actions to be taken by customers. Customers are to examine their inventory to determine if they have any of the affected products, and recommended to remove them from service in critical care areas, and contact Hospira to schedule removal and replacement of the motor. Replace affected devices with a loaner or corrected back-up pump if available. Custoemrs can contacvtd Hospira Global Product Safety and Complaints at 1-800-441-4100, and Technical Support Operations at 1-800-241-4002.
- Initiated
- 2010-02-22
- Root cause
- Device Design
- Terminated
- 2013-12-03
- Distribution
- Worldwide Distribution: USA and the coutnries of Australia, Canada, Colombia, Costa Rica, Malaysia, Mexico, Puerto Rico, Singapore and the UAE.
- Recall number
- Z-0128-2011
- Recall status
- Terminated
- CDRH record ID
- 93732
- FDA classified
- 2010-10-22
- Recall event number
- 56462